145720 — Dentium Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapContrarian

Market Cap
KR₩474bn
Enterprise Value
KR₩644bn
Revenue
KR₩408bn

Annual income statement for Dentium Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	229,749	291,530	355,866	393,189	407,807
Cost of Revenue
Gross Profit	142,797	193,154	260,676	278,839	260,251
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	191,058	223,121	230,163	252,227	319,953
Operating Profit	38,691	68,409	125,703	140,961	87,854
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	26,054	74,718	118,395	134,480	93,933
Provision for Income Taxes
Net Income After Taxes	22,220	55,499	86,144	96,526	72,410
Minority Interest
Net Income Before Extraordinary Items
Net Income	22,545	55,484	86,066	96,524	72,710
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	22,525	55,484	86,066	96,524	72,710
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2,657	6,507	9,980	11,106	9,445
Dividends per Share